ELI LILLY AND COMPANY Net Income
ELI LILLY AND COMPANY (LLY) reported Net Income of $7.09 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-08-05
- ELI LILLY AND COMPANY net income (loss) attributable to parent for the quarter ending 2026-06-30 was $7.09B, a 25.33% increase year-over-year.
- ELI LILLY AND COMPANY net income (loss) attributable to parent for the quarter ending 2026-03-31 was $7.40B, a 168.07% increase year-over-year.
- ELI LILLY AND COMPANY net income (loss) attributable to parent for the quarter ending 2025-12-31 was $6.64B, a 50.52% increase year-over-year.
- ELI LILLY AND COMPANY net income (loss) attributable to parent for the quarter ending 2025-09-30 was $5.58B, a 475.34% increase year-over-year.
- ELI LILLY AND COMPANY net income (loss) attributable to parent for fiscal 2025 was $20.64B, a 94.90% increase from fiscal 2024.
- ELI LILLY AND COMPANY net income (loss) attributable to parent for fiscal 2024 was $10.59B, a 102.10% increase from fiscal 2023.
- ELI LILLY AND COMPANY net income (loss) attributable to parent for fiscal 2023 was $5.24B, a 16.09% decline from fiscal 2022.
- ELI LILLY AND COMPANY net income (loss) attributable to parent for fiscal 2022 was $6.24B, a 11.88% increase from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.09B 10-Q · filed 2026-08-05 | $14.49B 10-Q · filed 2026-08-05 | $21.13B derived: sum of 3 quarters · filed 2026-08-05 | $26.71B derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $7.40B 10-Q · filed 2026-04-30 | $14.03B derived: sum of 2 quarters · filed 2026-04-30 | $19.62B derived: sum of 3 quarters · filed 2026-04-30 | $25.28B derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $6.64B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $12.22B derived: sum of 2 quarters · filed 2026-02-12 | $17.88B derived: sum of 3 quarters · filed 2026-08-05 | $20.64B 10-K · filed 2026-02-12 | |||
| 2025-09-30 | $5.58B 10-Q · filed 2025-10-30 | $11.24B derived: sum of 2 quarters · filed 2026-08-05 | $14.00B 10-Q · filed 2025-10-30 | $18.41B derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $5.66B 10-Q · filed 2026-08-05 | $5.66B 10-Q · filed 2025-08-07 | $8.42B 10-Q · filed 2026-08-05 | $8.42B 10-Q · filed 2025-08-07 | $12.83B derived: sum of 3 quarters · filed 2026-08-05 | $13.80B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $2.76B 10-Q · filed 2026-04-30 | $2.76B 10-Q · filed 2025-05-01 | $7.17B derived: sum of 2 quarters · filed 2026-04-30 | $8.14B derived: sum of 3 quarters · filed 2026-04-30 | $11.11B derived: sum of 4 quarters · filed 2026-04-30 | ||
| 2024-12-31 | $4.41B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $5.38B derived: sum of 2 quarters · filed 2026-02-12 | $8.35B derived: sum of 3 quarters · filed 2026-02-12 | $10.59B 10-K · filed 2026-02-12 | |||
| 2024-09-30 | $970.30M 10-Q · filed 2025-10-30 | $3.94B derived: sum of 2 quarters · filed 2025-10-30 | $6.18B 10-Q · filed 2025-10-30 | $8.37B derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-06-30 | $2.97B 10-Q · filed 2025-08-07 | $5.21B 10-Q · filed 2025-08-07 | $7.40B derived: sum of 3 quarters · filed 2026-02-12 | $7.34B derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-03-31 | $2.24B 10-Q · filed 2025-05-01 | $4.43B derived: sum of 2 quarters · filed 2026-02-12 | $4.37B derived: sum of 3 quarters · filed 2026-02-12 | $6.14B derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2023-12-31 | $2.19B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $2.13B derived: sum of 2 quarters · filed 2026-02-12 | $3.90B derived: sum of 3 quarters · filed 2026-02-12 | $5.24B 10-K · filed 2026-02-12 | $5.24B 10-K · filed 2024-02-21 | ||
| 2023-09-30 | -$57.40M 10-Q · filed 2024-10-30 | $1.71B derived: sum of 2 quarters · filed 2024-10-30 | $3.05B 10-Q · filed 2024-10-30 | $4.99B derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2023-06-30 | $1.76B 10-Q · filed 2024-08-08 | $3.11B 10-Q · filed 2024-08-08 | $5.05B derived: sum of 3 quarters · filed 2025-02-19 | $6.50B derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2023-03-31 | $1.34B 10-Q · filed 2024-04-30 | $3.28B derived: sum of 2 quarters · filed 2025-02-19 | $4.73B derived: sum of 3 quarters · filed 2025-02-19 | $5.69B derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2022-12-31 | $1.94B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $3.39B derived: sum of 2 quarters · filed 2025-02-19 | $4.34B derived: sum of 3 quarters · filed 2025-02-19 | $6.24B 10-K · filed 2025-02-19 | |||
| 2022-09-30 | $1.45B 10-Q · filed 2023-11-02 | $2.40B derived: sum of 2 quarters · filed 2023-11-02 | $4.31B 10-Q · filed 2023-11-02 | $6.03B derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $952.50M 10-Q · filed 2023-08-08 | $2.86B 10-Q · filed 2023-08-08 | $4.58B derived: sum of 3 quarters · filed 2024-02-21 | $5.69B derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | $1.90B 10-Q · filed 2023-04-27 | $3.63B derived: sum of 2 quarters · filed 2024-02-21 | $4.74B derived: sum of 3 quarters · filed 2024-02-21 | $6.13B derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $1.73B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $2.84B derived: sum of 2 quarters · filed 2024-02-21 | $4.23B derived: sum of 3 quarters · filed 2024-02-21 | $5.58B 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $1.11B 10-Q · filed 2022-11-01 | $2.50B derived: sum of 2 quarters · filed 2022-11-01 | $3.86B 10-Q · filed 2022-11-01 | $5.97B derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | $1.39B 10-Q · filed 2022-08-04 | $2.75B 10-Q · filed 2022-08-04 | $4.86B derived: sum of 3 quarters · filed 2023-02-22 | $6.07B derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | $1.36B 10-Q · filed 2022-04-29 | $3.47B derived: sum of 2 quarters · filed 2023-02-22 | $4.68B derived: sum of 3 quarters · filed 2023-02-22 | $6.09B derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | $2.12B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $3.33B derived: sum of 2 quarters · filed 2023-02-22 | $4.74B derived: sum of 3 quarters · filed 2023-02-22 | $6.19B 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $1.21B 10-Q · filed 2021-10-27 | $2.62B derived: sum of 2 quarters · filed 2021-10-27 | $4.08B 10-Q · filed 2021-10-27 | $5.57B derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2020-06-30 | $1.41B 10-Q · filed 2021-08-03 | $2.87B 10-Q · filed 2021-08-03 | $4.36B derived: sum of 3 quarters · filed 2022-02-23 | $5.62B derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2020-03-31 | $1.46B 10-Q · filed 2021-04-30 | $2.95B derived: sum of 2 quarters · filed 2022-02-23 | $4.21B derived: sum of 3 quarters · filed 2022-02-23 | $5.53B derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2019-12-31 | $1.50B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $2.75B derived: sum of 2 quarters · filed 2022-02-23 | $4.08B derived: sum of 3 quarters · filed 2022-02-23 | $8.32B 10-K · filed 2022-02-23 | |||
| 2019-09-30 | $1.25B 10-Q · filed 2020-10-28 | $2.58B derived: sum of 2 quarters · filed 2020-10-28 | $6.82B 10-Q · filed 2020-10-28 | $7.95B derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2019-06-30 | $1.33B 10-Q · filed 2020-07-31 | $5.57B 10-Q · filed 2020-07-31 | $6.69B derived: sum of 3 quarters · filed 2021-02-17 | $7.84B derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2019-03-31 | $4.24B 10-Q · filed 2020-05-01 | $5.37B derived: sum of 2 quarters · filed 2021-02-17 | $6.52B derived: sum of 3 quarters · filed 2021-02-17 | $6.26B derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2018-12-31 | $1.13B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $2.27B derived: sum of 2 quarters · filed 2021-02-17 | $2.01B derived: sum of 3 quarters · filed 2021-02-17 | $3.23B 10-K · filed 2021-02-17 | |||
| 2018-09-30 | $1.15B 10-Q · filed 2019-10-25 | $889.60M derived: sum of 2 quarters · filed 2019-10-25 | $2.11B 10-Q · filed 2019-10-25 | $450.10M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2018-06-30 | -$259.90M 10-Q · filed 2019-08-02 | $957.50M 10-Q · filed 2019-08-02 | -$699.40M derived: sum of 3 quarters · filed 2020-02-19 | -$143.80M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2018-03-31 | $1.22B 10-Q · filed 2019-05-02 | -$439.50M derived: sum of 2 quarters · filed 2020-02-19 | $116.10M derived: sum of 3 quarters · filed 2020-02-19 | $1.12B derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2017-12-31 | -$1.66B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$1.10B derived: sum of 2 quarters · filed 2020-02-19 | -$93.30M derived: sum of 3 quarters · filed 2020-02-19 | -$204.10M 10-K · filed 2020-02-19 | |||
| 2017-09-30 | $555.60M 10-Q · filed 2018-11-06 | $1.56B derived: sum of 2 quarters · filed 2018-11-06 | $1.45B 10-Q · filed 2018-11-06 | $2.22B derived: sum of 4 quarters · filed 2018-11-06 | |||
| 2017-06-30 | $1.01B 10-Q · filed 2018-07-25 | $897.20M 10-Q · filed 2018-07-25 | $1.67B derived: sum of 3 quarters · filed 2018-07-25 | $2.45B derived: sum of 4 quarters · filed 2018-07-25 | |||
| 2017-03-31 | -$110.80M 10-Q · filed 2018-04-27 | $661.00M derived: sum of 2 quarters · filed 2018-04-27 | $1.44B derived: sum of 3 quarters · filed 2018-04-27 | $2.19B derived: sum of 4 quarters · filed 2018-04-27 | |||
| 2016-12-31 | $771.80M 10-K · filed 2017-02-21 | $1.55B derived: sum of 2 quarters · filed 2017-10-27 | $2.30B derived: sum of 3 quarters · filed 2017-10-27 | $2.74B 8-K · filed 2019-10-24 | |||
| 2016-09-30 | $778.00M 10-Q · filed 2017-10-27 | $1.53B derived: sum of 2 quarters · filed 2017-10-27 | $1.97B 10-Q · filed 2017-10-27 | $2.44B derived: sum of 4 quarters · filed 2017-10-27 | |||
| 2016-06-30 | $747.70M 10-Q · filed 2017-07-28 | $1.19B 10-Q · filed 2017-07-28 | $1.67B derived: sum of 3 quarters · filed 2017-07-28 | $2.47B derived: sum of 4 quarters · filed 2017-07-28 | |||
| 2016-03-31 | $440.10M 10-Q · filed 2017-05-01 | $918.50M derived: sum of 2 quarters · filed 2017-05-01 | $1.72B derived: sum of 3 quarters · filed 2017-05-01 | $2.32B derived: sum of 4 quarters · filed 2017-05-01 | |||
| 2015-12-31 | $478.40M 10-K · filed 2017-02-21 | $1.28B derived: sum of 2 quarters · filed 2017-02-21 | $1.88B derived: sum of 3 quarters · filed 2017-02-21 | $2.41B 10-K · filed 2018-02-20 | |||
| 2015-09-30 | $799.70M 10-K · filed 2017-02-21 | $1.40B derived: sum of 2 quarters · filed 2017-02-21 | $1.93B 10-Q · filed 2016-10-28 | $2.36B derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-06-30 | $600.80M 10-K · filed 2017-02-21 | $1.13B 10-Q · filed 2016-07-28 | $1.56B derived: sum of 3 quarters · filed 2017-02-21 | $2.06B derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-03-31 | $529.50M 10-K · filed 2017-02-21 | $958.00M derived: sum of 2 quarters · filed 2017-02-21 | $1.46B derived: sum of 3 quarters · filed 2017-02-21 | $2.19B derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2014-12-31 | $428.50M 10-K · filed 2016-02-19 | $929.10M derived: sum of 2 quarters · filed 2016-02-19 | $1.66B derived: sum of 3 quarters · filed 2016-02-19 | $2.39B 10-K · filed 2017-02-21 | |||
| 2014-09-30 | $500.60M 10-K · filed 2016-02-19 | $1.23B derived: sum of 2 quarters · filed 2016-02-19 | $1.96B 10-Q · filed 2015-10-30 | $2.69B derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-06-30 | $733.50M 10-K · filed 2016-02-19 | $1.46B 10-Q · filed 2015-07-30 | $2.19B derived: sum of 3 quarters · filed 2016-02-19 | $3.39B derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-03-31 | $727.90M 10-K · filed 2016-02-19 | $1.46B derived: sum of 2 quarters · filed 2016-02-19 | $2.66B derived: sum of 3 quarters · filed 2016-02-19 | $3.86B derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2013-12-31 | $727.50M 10-K · filed 2015-02-19 | $1.93B derived: sum of 2 quarters · filed 2015-02-19 | $3.14B derived: sum of 3 quarters · filed 2015-02-19 | $4.68B 10-K · filed 2016-02-19 | |||
| 2013-09-30 | $1.20B 10-K · filed 2015-02-19 | $2.41B derived: sum of 2 quarters · filed 2015-02-19 | $3.96B 10-Q · filed 2014-10-29 | $4.78B derived: sum of 4 quarters · filed 2015-02-19 | |||
| 2013-06-30 | $1.21B 10-K · filed 2015-02-19 | $2.75B 10-Q · filed 2014-07-28 | $3.58B derived: sum of 3 quarters · filed 2015-02-19 | $4.91B derived: sum of 4 quarters · filed 2015-02-19 | |||
| 2013-03-31 | $1.55B 10-K · filed 2015-02-19 | $2.38B derived: sum of 2 quarters · filed 2015-02-19 | $3.70B derived: sum of 3 quarters · filed 2015-02-19 | $4.63B derived: sum of 4 quarters · filed 2015-02-19 | |||
| 2012-12-31 | $827.20M 10-K · filed 2014-02-19 | $2.15B derived: sum of 2 quarters · filed 2014-02-19 | $3.08B derived: sum of 3 quarters · filed 2014-02-19 | $4.09B 10-K · filed 2015-02-19 | |||
| 2012-09-30 | $1.33B 10-K · filed 2014-02-19 | $2.25B derived: sum of 2 quarters · filed 2014-02-19 | $3.26B 10-Q · filed 2013-10-30 | $4.12B derived: sum of 4 quarters · filed 2014-02-19 | |||
| 2012-06-30 | $923.60M 10-K · filed 2014-02-19 | $1.93B 10-Q · filed 2013-07-26 | $2.79B derived: sum of 3 quarters · filed 2014-02-19 | $4.03B derived: sum of 4 quarters · filed 2014-02-19 | |||
| 2012-03-31 | $1.01B 10-K · filed 2014-02-19 | $1.87B derived: sum of 2 quarters · filed 2014-02-19 | $3.11B derived: sum of 3 quarters · filed 2014-02-19 | $4.30B derived: sum of 4 quarters · filed 2014-02-19 | |||
| 2011-12-31 | $858.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-19 | $2.09B derived: sum of 2 quarters · filed 2014-02-19 | $3.29B derived: sum of 3 quarters · filed 2014-02-19 | $4.35B 10-K · filed 2014-02-19 | |||
| 2011-09-30 | $1.24B 10-Q · filed 2012-10-26 | $2.43B derived: sum of 2 quarters · filed 2012-10-26 | $3.49B 10-Q · filed 2012-10-26 | $4.66B derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2011-06-30 | $1.20B 10-Q · filed 2012-07-27 | $2.25B 10-Q · filed 2012-07-27 | $3.42B derived: sum of 3 quarters · filed 2013-02-21 | $4.73B derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2011-03-31 | $1.06B 10-Q · filed 2012-04-30 | $2.23B derived: sum of 2 quarters · filed 2013-02-21 | $3.53B derived: sum of 3 quarters · filed 2013-02-21 | $4.88B derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2010-12-31 | $1.17B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $2.47B derived: sum of 2 quarters · filed 2013-02-21 | $3.82B derived: sum of 3 quarters · filed 2013-02-21 | $5.07B 10-K · filed 2013-02-21 | |||
| 2010-09-30 | $1.30B 10-Q · filed 2011-10-28 | $2.65B derived: sum of 2 quarters · filed 2011-10-28 | $3.90B 10-Q · filed 2011-10-28 | $4.82B derived: sum of 4 quarters · filed 2012-02-24 | |||
| 2010-06-30 | $1.35B 10-Q · filed 2011-07-29 | $2.60B 10-Q · filed 2011-07-29 | $3.51B derived: sum of 3 quarters · filed 2012-02-24 | $4.45B derived: sum of 4 quarters · filed 2012-02-24 | |||
| 2010-03-31 | $1.25B 10-Q · filed 2011-04-29 | $2.16B derived: sum of 2 quarters · filed 2012-02-24 | $3.11B derived: sum of 3 quarters · filed 2012-02-24 | $4.26B derived: sum of 4 quarters · filed 2012-02-24 | |||
| 2009-12-31 | $915.40M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24 | $1.86B derived: sum of 2 quarters · filed 2012-02-24 | $3.02B derived: sum of 3 quarters · filed 2012-02-24 | $4.33B 10-K · filed 2012-02-24 | |||
| 2009-09-30 | $941.80M 10-Q · filed 2010-10-29 | $2.10B derived: sum of 2 quarters · filed 2010-10-29 | $3.41B 10-Q · filed 2010-10-29 | -$216.00M derived: sum of 4 quarters · filed 2011-02-22 | |||
| 2009-06-30 | $1.16B 10-Q/A · filed 2010-08-02 | $2.47B 10-Q/A · filed 2010-08-02 | -$1.16B derived: sum of 3 quarters · filed 2011-02-22 | -$1.62B derived: sum of 4 quarters · filed 2011-02-22 | |||
| 2009-03-31 | $1.31B 10-Q · filed 2010-07-30 | -$2.32B derived: sum of 2 quarters · filed 2011-02-22 | -$2.78B derived: sum of 3 quarters · filed 2011-02-22 | -$1.82B derived: sum of 4 quarters · filed 2011-02-22 | |||
| 2008-12-31 | -$3.63B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-22 | -$4.09B derived: sum of 2 quarters · filed 2011-02-22 | -$3.14B derived: sum of 3 quarters · filed 2011-02-22 | -$2.07B 10-K · filed 2011-02-22 | |||
| 2008-09-30 | -$465.60M 10-Q · filed 2009-10-30 | $493.20M derived: sum of 2 quarters · filed 2009-10-30 | $1.56B 10-Q · filed 2009-10-30 | ||||
| 2008-06-30 | $958.80M 10-Q · filed 2009-07-31 | $2.02B 10-Q · filed 2009-07-31 | |||||
| 2007-12-31 | $2.95B 10-K · filed 2010-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |